Cutaneous Melanoma

Dr. Charles M. Balch, M.D., FACS, Professor of Surgery, University of Texas Southwestern Medical Center, was previously Deputy Director for Clinical Trials and Outcomes Research at Johns Hopkins Institute and Executive Vice President and Chief Executive Officer of American Society of Clinical Oncology (ASCO). He has led a distinguished career as a clinical and academic oncologist for the past 35 years, as a leading authority in both melanoma and breast cancer. He has also made significant contributions to laboratory research in tumor immunology and human T lymphocyte differentiation. He is author of over 700 publications, which have been cited over 20,000 times in the biomedical literature, and has lectured in over 35 different countries in the world and most of the major academic centers in the United States. Dr. Balch is the founding Editor-in-Chief of the Annals of Surgical Oncology (Springer), which is recognized as the leading journal in the world in its field. He also held major leadership roles involving clinical research in three comprehensive cancer centers (University of Alabama at Birmingham, University of Texas M D Anderson, and the City of Hope National Medical center).
Jeffrey Gershenwald, MD, University of Texas, MD Anderson Cancer Center, Surgical Oncology
John Thompson, MD, Melanoma Institute of Australia, Surgical Oncology
Michael Atkins, MD, Georgetown Medical Center, Medical Oncology
John Kirkwood, MD, University of Pittsburgh, Medical Oncology
Richard Kefford, MD, University of Sydney, Medical Oncology
Arthur Sober, MD, Harvard Medical Center, Dermatology
Allan Halpern, MD, Memorial Sloan Kettering, Dermatology
Claus Garbe, University Hospital, Tuebingen, Dermatology